| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 72, 145-150, Copyright © 1991 by Endocrine Society
ARTICLES |
G Brabant, K Prank, C Hoang-Vu, RD Hesch and A von zur Muhlen
Department of Clinical Endocrinology, Medizinische Hochschule, Hannover, Germany.
To determine the mechanism underlying pulsatile TSH secretion, 24-h serum TSH levels were measured in three groups of five healthy volunteers by sampling blood every 10 min. The influence of an 8-h infusion of dopamine (200 mg), somatostatin (500 micrograms), or nifedipine (5 mg) on the pulsatile release of TSH was tested using a cross-over design. The amount of TSH released per pulse was significantly lowered by these drugs, resulting in significantly decreased mean basal TSH serum levels. However, pulses of TSH were still detectable at all times. The TSH response to TRH (200 micrograms) tested in separate experiments was significantly lowered after 3 h of nifedipine infusion compared to the saline control value. Nifedipine treatment did not alter basal, pulsatile, or TRH-stimulated PRL secretion. The persistence of TSH pulses under dopamine and somatostatin treatment and the blunted TSH responses to nifedipine infusion support the hypothesis that pulsatile TSH secretion is under the control of hypothalamic TRH. The 24-h TSH secretion pattern achieved under stimulation with exogenous TRH in two patients with hypothalamic destruction through surgical removal of a craniopharyngioma provided further circumstantial evidence for this assumption. No TSH pulses and low basal TSH secretion were observed under basal conditions (1700-2400 h), whereas subsequent repetitive TRH challenge (25 micrograms/2 h to 50 micrograms/1 h) led to a pulsatile release of TSH with fusion of TSH pulses, resulting in a TSH secretion pattern strikingly similar to the circadian variation. These data suggest that pulsatile and circadian TSH secretions are predominantly controlled by TRH.
This article has been cited by other articles:
![]() |
A. Mehta, P. C. Hindmarsh, R. G. Stanhope, C. E. Brain, M. A. Preece, and M. T. Dattani Is the Thyrotropin-Releasing Hormone Test Necessary in the Diagnosis of Central Hypothyroidism in Children J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5696 - 5703. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Porksen, M. Hollingdal, C. Juhl, P. Butler, J. D. Veldhuis, and O. Schmitz Pulsatile Insulin Secretion: Detection, Regulation, and Role in Diabetes Diabetes, February 1, 2002; 51(90001): S245 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kalsbeek, E. Fliers, A. N. Franke, J. Wortel, and R. M. Buijs Functional Connections between the Suprachiasmatic Nucleus and the Thyroid Gland as Revealed by Lesioning and Viral Tracing Techniques in the Rat Endocrinology, October 1, 2000; 141(10): 3832 - 3841. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Reed, A. I. Korytko, R. W. Hipkin, W. B. Wehrenberg, A. Schonbrunn, and L. Cuttler Pituitary Somatostatin Receptor (sst)1-5 Expression during Rat Development: Age-Dependent Expression of sst2 Endocrinology, October 1, 1999; 140(10): 4739 - 4744. [Abstract] [Full Text] |
||||
![]() |
R. Alvero, L. Kimzey, N. Sebring, J. Reynolds, M. Loughran, L. Nieman, and B. R. Olson Effects of Fasting on Neuroendocrine Function and Follicle Development in Lean Women J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 76 - 80. [Abstract] [Full Text] |
||||
![]() |
M. I. Surks and R. Sievert Drugs and Thyroid Function N. Engl. J. Med., December 21, 1995; 333(25): 1688 - 1694. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |